About the Company
We do not have any company description for MILESTONE SCIENTIFIC INC. at the moment.
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Employees
40
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MLSS News
Top 4 Health Care Stocks That May Plunge This Month
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum ...
ImmunityBio Inc. Drug Approved By FDA
A monumental achievement for ImmunityBio, Inc. occurred earlier this week, leaving the door open for potential major benefits ...
Labcorp to acquire Invitae in strategic deal
Invitae Corporation, a leading company in medical genetics, recently confirmed an agreement with Labcorp for the latter’s ...
Peninsula biotech co-founded by Jennifer Doudna lands CRISPR gene-editing pact with Regeneron
The big deal between Regeneron and a Peninsula biotech co-founded by Jennifer Doudna is also a small deal. And that’s a huge ...
Cidara Therapeutics: Now Well-Funded To Advance Its Cloudbreak Platform
Cidara Therapeutics, Inc. secures funding and focuses on oncology platform after passing rezafungin rights to Mundipharma.
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that it has passed ...
RVPH: Full Year 2023 Results
RVPH READ THE FULL RVPH RESEARCH REPORT 2023 Financial and Operational Results On April 15th, 2024, Reviva Pharmaceutical ...
Global Single-Use Filtration Assemblies Market Revenue to Cross US$ 19.28 Billion Milestone by 2033, Driven by Impressive 18.5% CAGR
The single-use filtration assemblies market is aiming to achieve a significant valuation of US$ 19.28 billion by 2033, ...
Petri Dish: Vertex scales cell manufacturing; German biotech enters Mass.
This week saw a German biotech announce its expansion to Greater Boston. Then, Boston’s own Vertex Pharmaceuticals looked ...
Sierra Nevada Wins $13B Contract to Upgrade US Air Force Fleet with New 'Doomsday' Nightwatch Planes
Sierra Nevada Corporation secures $13B contract to upgrade USAF's E-4B "Doomsday" fleet with Survivable Airborne Operations ...
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding ...
Medigene AG reports Financial Results and Business Update for Q1 2024
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today ...
Loading the latest forecasts...